COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS

Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA). Objective: to study the associations of the data of high-resolution computed tomography (HRCT) and the esti- mate of diffusing lung capacity (DLC) with clinical and laboratory parameters in RA pat...

Full description

Bibliographic Details
Main Authors: D. V. Bestaev, L. A. Bozhyeva, N. O. Nikonorova, S. I. Glukhova, D. E. Karateev, E. L. Nasonov
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-06-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/1939
id doaj-fc71675779824e6280230187fa44c9ef
record_format Article
spelling doaj-fc71675779824e6280230187fa44c9ef2021-08-02T09:05:46ZrusIMA-PRESS LLCНаучно-практическая ревматология1995-44841995-44922014-06-0152327728210.14412/1995-4484-2014-277-2821874COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITISD. V. Bestaev0L. A. Bozhyeva1N. O. Nikonorova2S. I. Glukhova3D. E. Karateev4E. L. Nasonov5Nasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaNasonova Research Institute of Rheumatology, Moscow, RussiaInterstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA). Objective: to study the associations of the data of high-resolution computed tomography (HRCT) and the esti- mate of diffusing lung capacity (DLC) with clinical and laboratory parameters in RA patients with and without ILD. Subjects and methods. 79 RA patients fulfilling the 1987 American College of Rheumatology criteria (61 women and 18 men) admitted to the Nasonova Research Institute of Rheumatology were included. Results. HRCT revealed signs of ILD in 58 (73%) cases. The patients with ILD were divided into three groups: 1) 18 (31%) patients with ground glass opacities; 2) 34 (58.6%) patients with fibrosis; 3) 6 (10.4%) patients with the honeycomb lung. Twenty-one (27%) patients with ILD were included in Group 4. In the ILD patients with ground glass opacities, the levels of anti-cyclic citrullinated peptide (ACCP) antibodies and rheumatoid factor (RF) were much above those in the patients without ILD (240 [166; 410.5], 480 [140; 850.5] and 73 [31; 101], 330,5 [118.5; 604.8], respectively). In the patients with ILD, the concentration of C-reactive protein (CRP) (46 [35; 91]) was higher than that in those without ILD (24 [18; 31]; p < 0.05). In the ILD patients with ground glass opacities, DLC was considerably below that in those with ILD – 59.2±11.2 and 79.8±12.1% of the normal value, respectively (p < 0.001). Conclusion. The associations found between ACCP antibodies and DLC, DAS28 and DLC may suggest that ACCP antibodies are implicated in the pathogenesis of ILD and the lung is involved in the immunoinflammatory process. The high percent of smokers detected in our investigation confirms the considerable role of smoking in the pathogene- sis of RA-associated ILD. In the RA patients with ILD, ground glass opacities must be an indicator of the activity of an immunopathological process in the lung.https://rsp.mediar-press.net/rsp/article/view/1939rheumatoid arthritishigh-resolution computed tomographydiffusing lung capacityanti-cyclic citrulli- nated peptide antibodiesrheumatoid factorc-reactive proteinsmoking.
collection DOAJ
language Russian
format Article
sources DOAJ
author D. V. Bestaev
L. A. Bozhyeva
N. O. Nikonorova
S. I. Glukhova
D. E. Karateev
E. L. Nasonov
spellingShingle D. V. Bestaev
L. A. Bozhyeva
N. O. Nikonorova
S. I. Glukhova
D. E. Karateev
E. L. Nasonov
COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
Научно-практическая ревматология
rheumatoid arthritis
high-resolution computed tomography
diffusing lung capacity
anti-cyclic citrulli- nated peptide antibodies
rheumatoid factor
c-reactive protein
smoking.
author_facet D. V. Bestaev
L. A. Bozhyeva
N. O. Nikonorova
S. I. Glukhova
D. E. Karateev
E. L. Nasonov
author_sort D. V. Bestaev
title COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
title_short COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
title_full COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
title_fullStr COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
title_full_unstemmed COMPARATIVE CLINICAL, LABORATORY, AND INSTRUMENTAL EVALUATION OF INTERSTITIAL LUNG CHANGES IN RHEUMATOID ARTHRITIS
title_sort comparative clinical, laboratory, and instrumental evaluation of interstitial lung changes in rheumatoid arthritis
publisher IMA-PRESS LLC
series Научно-практическая ревматология
issn 1995-4484
1995-4492
publishDate 2014-06-01
description Interstitial lung disease (ILD) is a common extra-articular manifestation of rheumatoid arthritis (RA). Objective: to study the associations of the data of high-resolution computed tomography (HRCT) and the esti- mate of diffusing lung capacity (DLC) with clinical and laboratory parameters in RA patients with and without ILD. Subjects and methods. 79 RA patients fulfilling the 1987 American College of Rheumatology criteria (61 women and 18 men) admitted to the Nasonova Research Institute of Rheumatology were included. Results. HRCT revealed signs of ILD in 58 (73%) cases. The patients with ILD were divided into three groups: 1) 18 (31%) patients with ground glass opacities; 2) 34 (58.6%) patients with fibrosis; 3) 6 (10.4%) patients with the honeycomb lung. Twenty-one (27%) patients with ILD were included in Group 4. In the ILD patients with ground glass opacities, the levels of anti-cyclic citrullinated peptide (ACCP) antibodies and rheumatoid factor (RF) were much above those in the patients without ILD (240 [166; 410.5], 480 [140; 850.5] and 73 [31; 101], 330,5 [118.5; 604.8], respectively). In the patients with ILD, the concentration of C-reactive protein (CRP) (46 [35; 91]) was higher than that in those without ILD (24 [18; 31]; p < 0.05). In the ILD patients with ground glass opacities, DLC was considerably below that in those with ILD – 59.2±11.2 and 79.8±12.1% of the normal value, respectively (p < 0.001). Conclusion. The associations found between ACCP antibodies and DLC, DAS28 and DLC may suggest that ACCP antibodies are implicated in the pathogenesis of ILD and the lung is involved in the immunoinflammatory process. The high percent of smokers detected in our investigation confirms the considerable role of smoking in the pathogene- sis of RA-associated ILD. In the RA patients with ILD, ground glass opacities must be an indicator of the activity of an immunopathological process in the lung.
topic rheumatoid arthritis
high-resolution computed tomography
diffusing lung capacity
anti-cyclic citrulli- nated peptide antibodies
rheumatoid factor
c-reactive protein
smoking.
url https://rsp.mediar-press.net/rsp/article/view/1939
work_keys_str_mv AT dvbestaev comparativeclinicallaboratoryandinstrumentalevaluationofinterstitiallungchangesinrheumatoidarthritis
AT labozhyeva comparativeclinicallaboratoryandinstrumentalevaluationofinterstitiallungchangesinrheumatoidarthritis
AT nonikonorova comparativeclinicallaboratoryandinstrumentalevaluationofinterstitiallungchangesinrheumatoidarthritis
AT siglukhova comparativeclinicallaboratoryandinstrumentalevaluationofinterstitiallungchangesinrheumatoidarthritis
AT dekarateev comparativeclinicallaboratoryandinstrumentalevaluationofinterstitiallungchangesinrheumatoidarthritis
AT elnasonov comparativeclinicallaboratoryandinstrumentalevaluationofinterstitiallungchangesinrheumatoidarthritis
_version_ 1721235922013388800